Product Description

Over the years, we have emerged as one of the leading organizations engaged in offering Mydacla Tablet. This tablet is indicated for use with sofosbuvir for the treatment of patients with chronic HCV genotype 3 infection. We procure this tablet with the help of our agents from reputed vendors. It is a direct-acting antiviral drug that target different steps of the hepatitis C virus (HCV) lifecycle. Packed in quality approved materials, Mydacla Tablet is available in different quantity packaging options.

Features:

• Longer shelf life
• Low indication of side effects
• Safe to consume
  

 Mydacla Tablet

• Medicine Name: Mydacla 60
• Active Ingredients: Daclatasvir Dihydrocloride Tablets
• Dosage Form: Tablets in bottle.
• Retail Pack: Pack of 28 Tablets
• Company Name: Mylan.